Showing results (211-220 of 1,931) with videos related to
Sort By:
Pageof 194
Molecular Microbiology|February 12, 2009
Pathogen trafficking pathways and host phosphoinositide metabolismStefan S Weber, Curdin Ragaz, Hubert HilbiPharmaceuticals (Basel, Switzerland)|January 9, 2021
B Cells and Antibodies as Targets of Therapeutic Intervention in Neuromyelitis Optica Spectrum DisordersJan Traub, Leila Husseini, Martin S WeberFrontiers in Immunology|March 13, 2020
High-Dose Vitamin D-Mediated Hypercalcemia as a Potential Risk Factor in Central Nervous System Demyelinating DiseaseDarius Häusler, Sebastian Torke, Martin S WeberCNS Drugs|September 30, 2022
Bruton's Tyrosine Kinase Inhibitors in Multiple Sclerosis: Pioneering the Path Towards Treatment of Progression?Anastasia Geladaris, Sebastian Torke, Martin S WeberDer Anaesthesist|May 19, 2019
[Health services research in intensive care medicine in Germany : Status quo and future challenges exemplified by acute pulmonary failure]S Blecha, S Weber-Carstens, T BeinInternational Journal of Molecular Sciences|April 3, 2021
Microglia: The Missing Link to Decipher and Therapeutically Control MS Progression?Anastasia Geladaris, Darius Häusler, Martin S WeberBiomedicines|March 28, 2024
Differential Role of Factor XIII in Acute Myocardial Infarction and Ischemic StrokeJan Traub, Martin S Weber, Anna FreyTrends in Neurosciences|December 15, 2023
Toward identifying key mechanisms of progression in multiple sclerosisLeila Husseini, Anastasia Geladaris, Martin S WeberDrug Design, Development and Therapy|July 28, 2026
Targeting Bruton's Tyrosine Kinase (BTK) in Autoimmunity: Achievements, Opportunities and ChallengesSebastian Torke, Sarah Dybowski, Martin S WeberDeutsche Medizinische Wochenschrift (1946)|May 16, 1975
[Heterogenicity of mitochondrial antibodies (author's transl)]P A Berg, T Binder, H Lindner, et al.Pageof 194